用SNEPI治疗13个月大的婴儿中度性亚托皮炎的新型非类固醇治疗方法:一个病例报告
Cheol-Jung Yang1,2, Sin-Hye Park3, Daewook Lee4
1Department of Orthopedic Surgery, Borntouch Orthopaedic Clinic, Seoul, Republic of Korea.
The Journal of dermatological treatment
|September 19, 2025
概括
交感神经捕获点注射 (SNEPI) 为儿科亚托皮性皮肤炎 (AD) 提供无类固醇治疗. 本案例研究表明,SNEPI有效地消除了AD症状,并保持了6年的缓解,突出了它在皮肤疾病中自主调节的潜力.
科学领域:
- 皮肤病学 皮肤病学
- 神经学 神经学
- 儿科 儿科 儿科
背景情况:
- 亚托皮炎 (AD) 是婴儿患的一种常见的慢性炎症性皮肤病.
- 目前的治疗方法,如局部皮质类固醇有局限性,需要替代疗法.
研究的目的:
- 评估交感神经捕获点注射 (SNEPI) 对儿科亚托皮炎的疗效和安全性.
- 探索自主调制在管理炎症性皮肤疾病中的作用.
主要方法:
- 一个13个月大的男性中度AD耐标准治疗的病例研究.
- SNEPI在T7副脊柱水平双边施用,每周用正常盐水进行三次治疗.
- 在治疗期间和六年随访期间监测的临床结果.
主要成果:
- 在第一次治疗后,完全消失,睡眠正常化.
- 在第三次会议之前,皮肤病变在没有皮质类固醇的情况下完全缓解.
- 在6年的随访期间,皮肤保持稳定,偶尔出现轻微的.
结论:
- SNEPI显示出作为儿童AD的安全,有效和无类固醇神经调节治疗的潜力.
- 支持自主调制可以有益于炎症性皮肤疾病的假设.
- 需要进一步的临床研究来确认SNEPI在儿科皮肤病学中的更广泛适用性.
关键词:
亚托邦性皮肤炎 (Atopic Dermatitis) 是一种不良的疾病.在SNEPI中,它是SNEPI.案例报告案例报告婴儿婴儿婴儿婴儿婴儿婴儿婴儿这是神经免疫系统.不使用类固醇治疗.同情神经系统的同情神经系统.更多相关视频
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
10.1K
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.6K
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K